msilverman@cooley.com
Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.
Download full bio
Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion
NeoPhotonics Agrees to Sell to Lumentum for $918 Million
Flexion Therapeutics Agrees to Sell to Pacira BioSciences
Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion
Cornerstone OnDemand Agrees to Sell to Clearlake Capital Group for $5.2 Billion
View all
Mergers & Acquisitions
Film, Music, Surfing and Travel
Fordham University School of Law JD, cum laude, 2012
University of VermontBA, Economics and Political ScienceHonors Program, 2006
California
New York
Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion December 15, 2021
NeoPhotonics Agrees to Sell to Lumentum for $918 Million November 8, 2021
Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion August 17, 2021
+1 858 550 6152
Locations